Pharmaceutical Technology Europe, Nov 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Pharmaceutical Technology Europe, Nov 1, 2010
Special Feature
Packaging: The Experts' View
By Carsten Peters , Piero Tomasi , Giuseppe Cardini , Agostino Consolini , Franz Ludwig , Jürgen Schafer
Leading European experts from the pharmaceutical packaging industry explain how they are coping with industry trends.
Is Pharma Doing Enough To reduce The Environmental Impact Of packaging?
By Jon Wear
Generally, the pharma industry isn't doing enough to reduce the environmental impact of its packaging materials, but there are various historic reasons for this.
Manufacturing
Designing An Effective PAT-Driven Scale-Up Of Lyophilization Processes
By Maik Guttzeit
This article examines the difficulties in designing lyophilisation processes that can be faithfully scaled up to production volumes and suggests the most effective ways in which this can be achieved.
Analytics
Dissolution Testing For Inhaled drugs
By Mark Copley , Yoen-Ju Son , Jason McConville
Although there are no regulatory requirements or established pharmacopoeial techniques for the dissolution testing of inhaled drugs, such testing can potentially open up the opportunity to tailor formulation properties.
Interview
Overcoming The Challenges Of Cell-Based BioProcessing
By Erika Lapinskas
Discussing the key challenges that face cell-based bioprocess manufacturers today, how these challenges might be addressed and the innovations that could facilitate the process in the future.
Industry Insider
Will Transatlantic Regulatory Cooperation Meet Expectations?
By Nathan Jessop
There has been increasing cooperation between the EMA and the FDA in recent years, and this looks set to continue in the future.
News
News
Joint regulatory API inspections on the rise.
Editor's Comment
Lessons in efficiency
By Fedra Pavlou
I recently attended the annual CPhI exhibition in Paris, which turned out to be a great event for the PTE team and I.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
18%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here